Implementation considerations for multisite clinical trials with cognitive neuroscience tasks

被引:16
作者
Keefe, Richard S. E. [1 ]
Harvey, Philip D. [2 ]
机构
[1] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA
[2] Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA
关键词
schizophrenia; clinical trials; cognition;
D O I
10.1093/schbul/sbn042
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Multisite clinical trials aimed at cognitive enhancement across various neuropsychiatric conditions have employed standard neuropsychological tests as outcome measures. While these tests have enjoyed wide clinical use and have proven reliable and predictive of functional disability, a number of implementation challenges have arisen when these tests are used in clinical trials. These issues are likely to be magnified in future studies when cognitive neuroscience (CN) procedures are explored in these trials, because in their current forms CN procedures are less standardized and more difficult to teach and monitor. For multisite trials, we anticipate that the most challenging issues will include assuring tester competence, monitoring tester performance, specific challenges with complex assessment methods, and having resources available for adequate monitoring of data quality. Suggestions for overcoming these implementation challenges are offered.
引用
收藏
页码:656 / 663
页数:8
相关论文
共 14 条
[1]   THE CONTINUOUS PERFORMANCE-TEST, IDENTICAL PAIRS VERSION .2. CONTRASTING ATTENTIONAL PROFILES IN SCHIZOPHRENIC AND DEPRESSED-PATIENTS [J].
CORNBLATT, BA ;
LENZENWEGER, MF ;
ERLENMEYERKIMLING, L .
PSYCHIATRY RESEARCH, 1989, 29 (01) :65-85
[2]   COGNITIVE IMPAIRMENT AS A TARGET FOR PHARMACOLOGICAL TREATMENT IN SCHIZOPHRENIA [J].
DAVIDSON, M ;
KEEFE, RSE .
SCHIZOPHRENIA RESEARCH, 1995, 17 (01) :123-129
[3]   Overlooking the obvious - A meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia [J].
Dickinson, Dwight ;
Ramsey, Mary E. ;
Gold, James M. .
ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (05) :532-542
[4]   A comparison of cognitive structure in schizophrenia patients and healthy controls using confirmatory factor analysis [J].
Dickinson, Dwight ;
Ragland, J. Daniel ;
Calkins, Monica E. ;
Gold, James M. ;
Gur, Ruben C. .
SCHIZOPHRENIA RESEARCH, 2006, 85 (1-3) :20-29
[5]   Treatment of cognitive impairment in early psychosis: A comparison of risperidone and haloperidol in a large long-term trial [J].
Harvey, PD ;
Rabinowitz, J ;
Eerdekens, M ;
Davidson, M .
AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (10) :1888-1895
[6]   Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment [J].
Harvey, PD ;
Keefe, RSE .
AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (02) :176-184
[7]   Efficiency of the CATIE and BACS neuropsychological batteries in assessing cognitive effects of antipsychotic treatments in schizophrenia [J].
Hill, S. Kristian ;
Sweeney, John A. ;
Hamer, Robert M. ;
Keefe, Richard S. E. ;
Perkins, Diana O. ;
Gu, Hongbin ;
Mcevoy, Joseph P. ;
Lieberman, Jeffrey A. .
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY, 2008, 14 (02) :209-221
[8]   Baseline neurocognitive deficits in the CATIE schizophrenia trial [J].
Keefe, Richard S. E. ;
Bilder, Robert M. ;
Harvey, Philip D. ;
Davis, Sonia M. ;
Palmer, Barton W. ;
Gold, James M. ;
Meltzer, Herbert Y. ;
Green, Michael F. ;
Miller, Del D. ;
Canive, Jose M. ;
Adler, Lawrence W. ;
Manschreck, Theo C. ;
Swartz, Marvin ;
Rosenheck, Robert ;
Perkins, Diana O. ;
Walker, Trina M. ;
Stroup, T. Scott ;
McEvoy, Joseph P. ;
Lieberman, Jeffrey A. .
NEUROPSYCHOPHARMACOLOGY, 2006, 31 (09) :2033-2046
[9]   The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: A review and meta-analysis [J].
Keefe, RSE ;
Silva, SG ;
Perkins, DO ;
Lieberman, JA .
SCHIZOPHRENIA BULLETIN, 1999, 25 (02) :201-222
[10]   The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery [J].
Keefe, RSE ;
Goldberg, TE ;
Harvey, PD ;
Gold, JM ;
Poe, MP ;
Coughenour, L .
SCHIZOPHRENIA RESEARCH, 2004, 68 (2-3) :283-297